Mesalazine associated nephrogenic diabetes insipidus presenting as weight loss.
about
sameAs
Polyuria and weight-loss associated with cimetidineCisplatin-induced hyperactivity in the dorsal cochlear nucleus and its relation to outer hair cell loss: relevance to tinnitus.Review article: interstitial nephritis associated with the use of mesalazine in inflammatory bowel disease.Indications for 5-aminosalicylate in inflammatory bowel disease: is the body of evidence complete?Therapeutic potential of growth factors and their antagonists.Renal manifestations and complications of inflammatory bowel disease.Do gastroenterologists monitor their patients taking 5-amino-salicylates following initiation of treatmentAcute kidney injury in a girl with ulcerative colitis and cytomegalovirus-induced focal segmental glomerular sclerosis.Chronic tubulointerstitial nephritis induced by 5-aminosalicylate in an ulcerative colitis patient: a rare but serious adverse event.Renal tubular injury is present in acute inflammatory bowel disease prior to the introduction of drug therapy.Evaluation of renal function following treatment with 5-aminosalicylic acid derivatives in patients with ulcerative colitis.
P2860
Q28318042-63222465-E51D-469B-B0E8-58911220E282Q30841065-F33DD57C-9800-4DC1-A5A7-180C1B325CF3Q33815735-059DA44A-A81B-4C95-BCF4-4D3EA6C1D0B0Q33868970-C285668C-01EF-40A6-A4BB-5CC0EA3CC7DFQ35242622-09CB5CC1-7CD2-425B-90F5-BFEA71CC9E15Q37789000-933224A7-6873-4720-8DE1-FA4A3E4D4C66Q38609002-CEFAF514-A62B-49F0-A57F-02784D7E783DQ40313960-1E07BC13-4D9D-4909-B5B3-A27F1731AB71Q40747451-2573F7B4-1399-4B40-9EFF-DEFAA438FED8Q43687351-320B0088-0970-450A-9C07-FFDC21864533Q43892494-3356E1B7-F780-4983-9A52-21065926926E
P2860
Mesalazine associated nephrogenic diabetes insipidus presenting as weight loss.
description
1992 nî lūn-bûn
@nan
1992 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Mesalazine associated nephrogenic diabetes insipidus presenting as weight loss
@nl
Mesalazine associated nephrogenic diabetes insipidus presenting as weight loss.
@ast
Mesalazine associated nephrogenic diabetes insipidus presenting as weight loss.
@en
type
label
Mesalazine associated nephrogenic diabetes insipidus presenting as weight loss
@nl
Mesalazine associated nephrogenic diabetes insipidus presenting as weight loss.
@ast
Mesalazine associated nephrogenic diabetes insipidus presenting as weight loss.
@en
prefLabel
Mesalazine associated nephrogenic diabetes insipidus presenting as weight loss
@nl
Mesalazine associated nephrogenic diabetes insipidus presenting as weight loss.
@ast
Mesalazine associated nephrogenic diabetes insipidus presenting as weight loss.
@en
P2860
P356
P1433
P1476
Mesalazine associated nephrogenic diabetes insipidus presenting as weight loss.
@en
P2093
P2860
P304
P356
10.1136/GUT.33.4.563
P407
P577
1992-04-01T00:00:00Z